(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 18.94%502.25B | 15.76%301.13B | 3.97%124.94B | 42.04%602.32B | 57.75%422.27B | 72.72%260.12B | 79.83%120.17B | 96.20%424.06B | 84.37%267.69B | 65.71%150.61B |
Operating income | 18.94%502.25B | 15.76%301.13B | 3.97%124.94B | 42.04%602.32B | 57.75%422.27B | 72.72%260.12B | 79.83%120.17B | 96.20%424.06B | 84.37%267.69B | 65.71%150.61B |
Operating expenses | -17.49%-397.95B | -13.37%-240.86B | 1.12%-97.6B | -36.59%-480.56B | -50.45%-338.73B | -63.09%-212.45B | -68.62%-98.71B | -87.14%-351.82B | -78.19%-225.15B | -64.30%-130.27B |
Gross profit | 24.84%104.3B | 26.42%60.27B | 27.36%27.34B | 68.53%121.76B | 96.39%83.55B | 134.36%47.67B | 159.03%21.47B | 156.69%72.24B | 125.82%42.54B | 75.35%20.34B |
Selling expenses | -38.85%-23.92B | -32.10%-14.32B | -46.37%-6.8B | -67.40%-25.21B | -84.13%-17.23B | -129.49%-10.84B | -134.96%-4.65B | -147.64%-15.06B | -119.70%-9.36B | -78.07%-4.72B |
Administrative expenses | -20.71%-12.41B | -12.85%-7.69B | -11.97%-3.77B | -34.52%-13.46B | -60.39%-10.28B | -85.77%-6.82B | -97.77%-3.37B | -75.25%-10.01B | -69.41%-6.41B | -52.49%-3.67B |
Research and development expenses | -33.61%-33.32B | -41.82%-19.62B | -70.10%-10.61B | -112.15%-39.57B | -129.42%-24.94B | -155.05%-13.83B | -164.24%-6.24B | -133.44%-18.65B | -107.69%-10.87B | -81.07%-5.42B |
Profit from asset sales | -130.45%-37.51M | -111.10%-8.41M | -110.22%-4.29M | 933.92%90.36M | 671.13%123.17M | 415.11%75.77M | 1,147.67%42.02M | -114.06%-10.84M | -108.40%-21.57M | -492.00%-24.05M |
Revaluation surplus | 48.35%395.89M | 300.16%347.72M | 76.99%142.76M | 104.40%257.74M | 661.05%266.86M | 641.71%86.9M | -28.26%80.66M | 166.28%126.1M | -183.16%-47.56M | -156.56%-16.04M |
-Changes in the fair value of other assets | 48.35%395.89M | 300.16%347.72M | 76.99%142.76M | 104.40%257.74M | 661.05%266.86M | 641.71%86.9M | -28.26%80.66M | 166.28%126.1M | -183.16%-47.56M | -156.56%-16.04M |
Impairment and provision | -54.37%-3.75B | -53.10%-2.32B | -34.25%-969.17M | -58.58%-3.77B | -67.68%-2.43B | -129.60%-1.52B | -168.03%-721.91M | -90.76%-2.38B | -318.28%-1.45B | -142.84%-660.15M |
-Other impairment is provision | -54.37%-3.75B | -53.10%-2.32B | -34.25%-969.17M | -58.58%-3.77B | -67.68%-2.43B | -129.60%-1.52B | -168.03%-721.91M | -90.76%-2.38B | -318.28%-1.45B | -142.84%-660.15M |
Special items of operating profit | 187.52%10.91B | 146.43%6.03B | 159.13%2.42B | 641.32%6.89B | 363.46%3.8B | 774.79%2.45B | 21,894.18%933.21M | -58.01%929.23M | -44.64%818.86M | -69.44%279.89M |
Operating profit | 29.21%32.77B | 37.72%17.39B | 5.66%5.6B | 83.84%36.63B | 136.05%25.37B | 239.14%12.63B | 441.16%5.3B | 210.39%19.92B | 105.04%10.75B | 17.39%3.72B |
Financing cost | -180.75%-1.03B | -106.26%-69.01M | 3,381.91%193.96M | -8.84%1.47B | -5.05%1.27B | 22.76%1.1B | -107.30%-5.91M | 190.54%1.62B | 197.65%1.34B | 194.00%898.45M |
Special items of earning before tax | 25.32%-427.09M | 71.29%-95.14M | 0.30%-81.12M | -80.58%-834.46M | -1,794.66%-571.88M | -1,811.14%-331.36M | -1,103.45%-81.37M | -305.38%-462.09M | -41.48%33.75M | 259.71%19.37M |
Earning before tax | 20.16%31.32B | 28.57%17.23B | 9.59%5.72B | 76.80%37.27B | 115.08%26.07B | 188.70%13.4B | 394.78%5.22B | 366.57%21.08B | 208.65%12.12B | 110.58%4.64B |
Tax | -35.65%-5.07B | -58.91%-3.11B | -11.71%-946.49M | -75.98%-5.92B | -75.48%-3.74B | -176.73%-1.96B | -492.71%-847.24M | -511.29%-3.37B | -238.26%-2.13B | -80.08%-708.35M |
After-tax profit from continuing operations | 17.56%26.25B | 23.37%14.11B | 9.17%4.77B | 76.95%31.34B | 123.52%22.33B | 190.85%11.44B | 379.42%4.37B | 346.48%17.71B | 202.99%9.99B | 117.21%3.93B |
Earning after tax | 17.56%26.25B | 23.37%14.11B | 9.17%4.77B | 76.95%31.34B | 123.52%22.33B | 190.85%11.44B | 379.42%4.37B | 346.48%17.71B | 202.99%9.99B | 117.21%3.93B |
Minority profit | 5.20%1.01B | -0.74%481.96M | -15.77%202.09M | 19.49%1.3B | 41.76%959.53M | 43.72%485.57M | 132.71%239.93M | 18.28%1.09B | -20.69%676.89M | -46.98%337.86M |
Profit attributable to shareholders | 18.12%25.24B | 24.44%13.63B | 10.62%4.57B | 80.72%30.04B | 129.47%21.37B | 204.68%10.95B | 410.89%4.13B | 445.86%16.62B | 281.13%9.31B | 206.35%3.6B |
Basic earnings per share | 18.10%8.68 | 24.14%4.68 | 10.56%1.57 | 80.74%10.32 | 129.69%7.35 | 204.03%3.77 | 407.14%1.42 | 438.68%5.71 | 276.47%3.2 | 202.44%1.24 |
Diluted earnings per share | 18.10%8.68 | 24.14%4.68 | 10.56%1.57 | 80.74%10.32 | 129.69%7.35 | 204.03%3.77 | 407.14%1.42 | 438.68%5.71 | 276.47%3.2 | 202.44%1.24 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data